A
AFYREN
A company specialized in microbiology and bioprocess engineering for the valorization of non-food biomass in bioenergy and green chemistry
About AFYREN
AFYREN operates in the bioeconomy sector, focusing on producing biomolecules that serve as sustainable alternatives to petrochemical products. The company targets industrial clients seeking to reduce their ecological footprint by integrating biobased solutions into their production processes. AFYREN's business model revolves around leveraging its proprietary technology to manufacture a range of organic acids, which are used as ingredients in various applications. Revenue is generated through the sale of these biobased products, which are positioned as environmentally friendly and compliant with international standards for natural raw materials. The company operates its first manufacturing plant, AFYREN NEOXY, in collaboration with the SPI Fund, highlighting its commitment to industrial partnerships. AFYREN's market strategy is aligned with the global shift towards a circular and regenerative economy, aiming to contribute to better health for people and ecosystems. The company's approach is characterized by adaptability to the evolving needs of its clients and society, ensuring its relevance in a rapidly changing world. Keywords: biomolecules, bioeconomy, organic acids, sustainability, low-carbon, biobased, petrochemical alternatives, ecological footprint, circular economy, regenerative.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Clermont-Ferrand, France
- Listing
- IPO 2021
- Employees
- 146
- Open positions
- 13
- Dealroom signal
- 87.2/100
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Biomass, Spinout, Sustainable Development Goals, Climate Tech, B Corp, Energy and Greentech, Observatoire Deeptech, Clean Industry, Greentech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Apr 2026 | $3.3M | — | European Commission | ↗ |
| POST IPO EQUITY✓Other financing | Feb 2026 | $7.7M | — | Odyssée Venture | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for AFYREN is 5K monthly website visits, up 163.2% over the last three months. AFYREN's team grew 11.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Commission
Series A1 investor entered at this stage
Sofimac Régions
Series B and later6 investors entered at this stage
Sofinnova Partners
Valquest Partners
Supernova
Crédit Agricole
Bpifrance
Odyssée Venture
Other known investors9 additional known investors
Institut Pascal - Clermont Auvergne University
Clermont Auvergne Innovation
Clermont Auvergne University
CNRS Innovation
French National Centre for Scientific Research - CNRS
Polytechnic Institute of Clermont-Auvergne - Clermont Auvergne University
777 CORP
Julien Lopizzo
Supernova Invest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AFYREN on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AFYREN’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







